AIP
TEVA icon

Ameritas Investment Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Ameritas Investment Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,000
Closed -$35K – 2976
2017
Q3 		$35K Hold
2,000
– – ﹤0.01% 2088
2017
Q2 		$66K Hold
2,000
– – ﹤0.01% 1723
2017
Q1 		$64K Hold
2,000
– – ﹤0.01% 1686
2016
Q4 		$72K Hold
2,000
– – ﹤0.01% 1100
2016
Q3 		$92K Hold
2,000
– – 0.01% 1070
2016
Q2 		$100K Hold
2,000
– – 0.01% 999
2016
Q1 		$107K Hold
2,000
– – 0.01% 988
2015
Q4 		$131K Hold
2,000
– – 0.01% 965
2015
Q3 		$112K Buy
+2,000
New +$130K 0.01% 961

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Ameritas Investment Partners's TEVA Position: Q4 2017 in Review

Ameritas Investment Partners sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 2,000 shares — an estimated $35K sold.

Ameritas Investment Partners first reported a position in TEVA in Q3 2015 and held it in 9 quarters. The position peaked at $131K in Q4 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Ameritas Investment Partners reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,000 Teva Pharmaceuticals shares in Q4 2017, an estimated $35K.
  • Ameritas Investment Partners first reported a position in Teva Pharmaceuticals in Q3 2015 and held it in 9 quarters.
  • Ameritas Investment Partners's Teva Pharmaceuticals position peaked at $131K in Q4 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Ameritas Investment Partners's 13F filing for Q4 2017, filed 14 Feb 2018.